Search the Newsreel

Is Teladoc Health (TDOC) Undervalued As Teladoc One Tests The AI Health Threat?

Teladoc Health (TDOC) is gaining attention after launching Teladoc One, an AI-supported virtual care platform, amidst discussions around the impact of AI in healthcare. Despite a strong recent share price rebound of 52.52% over 90 days and 24.40% year-to-date, its five-year return is down …

TELA Bio Inc (TELA) Institutional Confidence

TELA Bio Inc (TELA) has an institutional shareholding score of 7.00, placing it 79th out of 200 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 73.39%, showing a slight quarter-over-quarter decrease of 2.93%. James Simons is the largest institutional shareholder, …

TDOC, AMWL Stocks Retreat After OpenAI Lets Users Link Medical Records To ChatGPT

Shares of telehealth platforms Teladoc Health (TDOC) and American Well Corp (AMWL) fell after OpenAI launched an expanded Health experience in ChatGPT, allowing users to link personal health data for personalized responses. This new feature overlaps with services offered by telehealth companies, potentially causing …

Teladoc, GoodRx shares fall on OpenAI health feature launch

Shares of Teladoc Inc (NYSE:TDOC) and GoodRx Holdings Inc (NASDAQ:GDRX) fell after OpenAI unveiled a new health feature in ChatGPT. This feature allows U.S. users to connect medical records and Apple Health data to the AI chatbot, enabling tasks like comparing lab results and …

Teladoc (TDOC) Shares Decline in Afternoon Trading

Teladoc Health Inc. (TDOC) saw its shares drop by 3% in afternoon trading on July 23, 2026, closing at $8.64. This decline is attributed to ongoing challenges in the telehealth sector, reflected in the company's moderate GF Score™ of 61 and insider selling activities …

Teladoc launches personalized, risk-based virtual care model

Teladoc Health has introduced Teladoc One, a new personalized, risk-based virtual care model leveraging an AI-driven engine to unify services, care teams, and data. This model aims to deliver individualized care by linking payments to medical cost savings and clinical outcomes, initially focusing on …

Teladoc (TDOC) Stock May Be 41% Undervalued On Cash Flow Strength

Teladoc Health (TDOC) stock appears significantly undervalued, trading at an estimated 41.3% discount based on a Discounted Cash Flow (DCF) analysis, which projects future cash flows. Despite a 94.1% decline over the past five years, its current price of around US$8.92 is considered cheap …

Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care

Teladoc Health has announced Teladoc One, a new virtual care model designed to address fragmented healthcare by providing personalized, adaptive, and connected care. This model, launching with select clients in September 2026, leverages AI and multidisciplinary teams to coordinate care across various settings and …

Teladoc Health Introduces Teladoc One To Deliver Connected And Adaptive Virtual Care

Teladoc Health has launched Teladoc One, a new virtual care model designed to provide a connected, predictive, and adaptive healthcare experience tailored to individuals. This model aims to address fragmented care by integrating various health data points through its Pulse intelligence engine and coordinating …

Teladoc Health launches new virtual care model with fees at risk

Teladoc Health has introduced "Teladoc One," a new virtual care model that integrates various health services into a single platform. This model employs multidisciplinary care teams and AI-driven intelligence to coordinate care. Significantly, Teladoc Health is placing 100% of its fees at risk, linking …

Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results

Teladoc Health has launched Teladoc One, a new virtual care model for employers and health plans that integrates care across various health needs, moving away from fragmented, condition-specific programs. The model aims to improve clinical outcomes and reduce healthcare costs, with 100% of Teladoc's …

Teladoc Health (TDOC) Q2 2024 earnings summary

Teladoc Health (TDOC) reported a Q2 2024 revenue decline of 2% year-over-year to $642.4 million, largely due to lower performance in its BetterHelp segment, resulting in a net loss of $837.7 million driven by a significant non-cash goodwill impairment charge. Despite this, adjusted EBITDA …

Daily Special: Altoro Metals, Carnegie Clean Energy, Mastermyne Group, Eden Innovations, Stelar Metals

CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $11

CCORF has reiterated its Buy rating for Teladoc Health (TDOC.US) and increased its target price to $11. This indicates continued confidence in the company's performance and future prospects.

TELA Bio to Announce Second Quarter 2026 Financial Results

TELA Bio, Inc. (NASDAQ: TELA) announced that it will report its second quarter 2026 financial results on Monday, August 10, 2026. The company's management will host a conference call and webcast at 4:30 p.m. ET on that day to discuss the results and provide …

TELA Bio sets Aug. 10 webcast for second-quarter update

TELA Bio (NASDAQ: TELA) announced it will report its second-quarter 2026 financial results on Monday, August 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results and provide a corporate update. Investors …

TELA Bio (TELA) awards director 6,227 fully vested compensation shares

TELA Bio director Joseph H. Capper was granted 6,227 fully vested shares of common stock on July 15, 2026, as compensation in lieu of cash, valuing the grant at $0.785 per share for a total of approximately $5,000. Following this transaction, Capper directly owns …

TELA Bio (TELA) director granted 20,930 fully vested shares

TELA Bio, Inc. director William J. Plovanic was granted 20,930 fully vested shares of common stock, valued at $0.785 per share, as compensation. These shares were issued in lieu of cash under the company’s Amended and Restated Non-Employee Director Compensation Policy. This transaction increases …

Form 4 Tela Bio Inc For: 17 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Tela Bio Inc. on July 17. The brief report highlights the financial news related to the company, indicating insider trading activity that public Form 4 filings are designed to disclose. The stock TELA …

Teladoc Health (TDOC) Faces Fresh Growth Concerns, Is It Still Overvalued?

Teladoc Health (TDOC) is facing new growth concerns regarding flat sales and declining revenue per user, despite a recent surge in its stock price. While one analysis suggests the stock is 28% overvalued with a fair value of $7.40, another view using a sales …

Teladoc Health to Announce Second Quarter 2026 Financial Results

Teladoc Health Inc. will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after the market closes. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the results, with details provided for both …

Teladoc (TDOC) Stock May Be 39% Below Fair Value As Insurance Expansion Grows

Teladoc Health (TDOC) stock appears undervalued, with valuation checks suggesting it trades at a discount of about 39% below its intrinsic value. Despite a 94% decline over the past five years, the Discounted Cash Flow (DCF) model and sales-based multiples indicate that a recent …

Teladoc Health to Release Q2 Results After Market Close

Teladoc Health (NYSE: TDOC) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after market close. The company will host a conference call at 5:00 p.m. ET on the same day to review the results, with U.S. participants …

Stelar Metals (ASX:SLB) Jumps as Tungsten Exploration Expands

TELA Forecast — Price Target — Prediction for 2027

Teladoc Health (TDOC) Stock Valuation As Analyst Sentiment Improves Despite Expected Earnings Decline

Sunrise Energy Metals (ASX:SRL) Gains as Critical Minerals Demand Remains in Focus

Teladoc (TDOC) Up 23.9% Since Last Earnings Report: Can It Continue?

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

Stelar Metals (ASX:SLB) Soars on Strategic Tungsten Project Acquisition

TELA Bio Reports First Quarter 2026 Financial Results

The 5 Most Interesting Analyst Questions From Teladoc’s Q1 Earnings Call

TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness

$19M Q1 tops TELA Bio outlook as 4 new directors join

How Teladoc’s Narrower Q1 Loss Amid Softer Revenue At Teladoc Health (TDOC) Has Changed Its Investment Story

Teladoc Health, Inc. Q1 2026 Earnings Call Summary